Henry M Jackson Foundation For The Advancement of Military Medicine

As trusted partners with military medical researchers, important HJF accomplishments include attracting, managing and retaining highly qualified scientific staff to support the priorities of U.S. military medicine. Whether it is the senior scientist to lead major initiatives and work collaboratively with U.S. government scientists, or lab techs to perform ongoing research functions, HJF hires the best and brightest talent to accelerate innovations necessary to advance military medicine. In FY2023, HJF celebrated 40 years of meeting its mission of advancing military medicine. HJF undertook several research initiatives in new geographic regions, one of which was to evaluate wartime medical care delivery provided by the Ukraine Ministry of Health. We launched a new Innovation Ecosystem initiative with multiple new partners, including a high-profile event with the Maryland Technology Development Corporation (TEDCO). We also strengthened our collaborations across U.S. federal agencies, universities, non-governmental organizations, and private industry. Supported HJF Programs PEPFAR: Since 2005, HJF Medical Research International has implemented the U.S. President's Emergency Plan for AIDS Release (PEPFAR) HIV prevention, care and treatment services across four countries in Africa. This year marked the 20th anniversary of the PEPFAR program, and with improved treatments, HIV is no longer a death sentence, and stigma around the disease has decreased in many African communities. MHRP: The U.S. Military HIV Research Program (MHRP) identified two novel broadly neutralizing monoclonal antibodies that show promise for the prevention and treatment of HIV, and they may be particularly useful in military settings. HJF's Global Infectious Diseases portfolio continues to broaden its services to help defeat current and future infectious diseases through support of the Emerging Infectious Disease, Diagnostic and Countermeasures, and One Health branches at Walter Reed Army Institute of Research. IDCRP: The Infectious Disease Clinical Research Program (IDCRP) has more than 100 HJF employees across more than 35 partner clinical sites, along with many ongoing collaborations with academia, industry and other government partners. For FY2023, one of IDCRP's example studies is a follow-on trial to evaluate the efficacy of a lower dose of rifaximin to treat travelers' diarrhea. ACESO: The Austere environments Consortium for Enhanced Sepsis Outcomes (ACESO) continued its efforts to discover host-biomarkers of severe infections and sepsis utilizing advanced data analytics and artificial intelligence/machine learning, set up an intuitive clinical data management system, transition host-biomarkers to point-of-care devices that are being validated at host country institutions, publish peer-reviewed manuscripts of the scientific community and expand its observational studies in severe infections and sepsis to Madagascar and Peru. In FY2023, HJF received more than 270 new awards, grants, agreements, or contracts. HJF had more than 1400 active research protocols during FY2023 with a presence in 17 countries, and approximately 2,800 teammates at sites on four continents.

Education accounts provided educational, training, and other approved initiatives related to advancing military medicine. Samples of projects funded through educational initiatives include the provisioning of textbooks, travel to medical conferences or courses, support for exams, and manuscript publication expenses.

Endowments delivered significant program services and support to the Uniformed Services University for the Health Sciences (USU), particularly for the School of Medicine and the clinical sciences Department of Surgery and Department of Dermatology. Programs include fellowship grants for graduate students studying military medicine at USU. HJF Fellowship Awards provide travel, education, and training support.